Zobrazeno 1 - 10
of 265
pro vyhledávání: '"Cox, LS"'
Autor:
Cartujano-Barrera F, Arana-Chicas E, Ramírez-Mantilla M, Perales J, Cox LS, Ellerbeck EF, Catley D, Cupertino AP
Publikováno v:
Patient Preference and Adherence, Vol Volume 13, Pp 1213-1219 (2019)
Francisco Cartujano-Barrera,1 Evelyn Arana-Chicas,1 Mariana Ramírez-Mantilla,2 Jaime Perales,2 Lisa Sanderson Cox,2 Edward F Ellerbeck,2 Delwyn Catley,3 Ana Paula Cupertino11Department of Cancer Prevention and Control, Hackensack University Medical
Externí odkaz:
https://doaj.org/article/9c3f03979bb34783872e7cb91eb17e2d
Publikováno v:
Frontiers in physiology. 13
Bone is a complex organ serving roles in skeletal support and movement, and is a source of blood cells including adaptive and innate immune cells. Structural and functional integrity is maintained through a balance between bone synthesis and bone deg
Cellular senescence, a state of essentially irreversible proliferation arrest, serves as a potent tumour suppressor mechanism. However, accumulation of senescent cells with chronological age is likely to contribute to loss of tissue and organ functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1ad379d312fc4ddd8ec9bc20084b7f3c
https://ora.ox.ac.uk/objects/uuid:2ca99f8e-2e9f-4eea-9fde-a1faf3a7f022
https://ora.ox.ac.uk/objects/uuid:2ca99f8e-2e9f-4eea-9fde-a1faf3a7f022
Autor:
Benowitz, Neal, Zhu, AZX, Zhou, Q, Cox, LS, David, SP, Ahluwalia, JS, Benowitz, NL, Tyndale, RF
Publikováno v:
Benowitz, Neal; Zhu, AZX; Zhou, Q; Cox, LS; David, SP; Ahluwalia, JS; et al.(2014). Association of CHRNA5-A3-B4 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/5gv7d7nd
Associations between CHRNA5-A3-B4 variants and smoking behaviors exist; however, the association with smoking abstinence is less understood, particularly that among African Americans. In 1,295 African Americans enrolled in two clinical trials, we inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::e61f48b8c6646b3447f9e62bf1aec9f1
http://www.escholarship.org/uc/item/5gv7d7nd
http://www.escholarship.org/uc/item/5gv7d7nd
Publikováno v:
Zhu, AZX; Zhou, Q; Cox, LS; David, SP; Ahluwalia, JS; Benowitz, NL; et al.(2014). Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. Clinical Pharmacology and Therapeutics, 96(2), 256-265. doi: 10.1038/clpt.2014.88. UCSF: Retrieved from: http://www.escholarship.org/uc/item/78w8c34k
Associations between CHRNA5-A3-B4 variants and smoking behaviors exist; however, the association with smoking abstinence is less understood, particularly that among African Americans. In 1,295 African Americans enrolled in two clinical trials, we inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::d9ba4f69850d76a2783b3b6eb2ddb32a
http://www.escholarship.org/uc/item/78w8c34k
http://www.escholarship.org/uc/item/78w8c34k
Publikováno v:
Zhu, AZX; Zhou, Q; Cox, LS; Ahluwalia, JS; Benowitz, NL; & Tyndale, RF. (2014). Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes. Drug Metabolism and Disposition, 42(11), 1971-1977. doi: 10.1124/dmd.114.060285. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6qm655sb
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics. Bupropion is used clinically to treat depression and to promote smoking cessation. It is metabolized by CYP2B6 to its active metabolite hydroxybupropion, yet al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::b4bd7e41b80eb5a67a7d4f4fff163a40
http://www.escholarship.org/uc/item/6qm655sb
http://www.escholarship.org/uc/item/6qm655sb
Publikováno v:
Benowitz, Neal; Zhu, AZX; Zhou, Q; Cox, LS; Ahluwalia, JS; Benowitz, NL; et al.(2013). Variation in Trans-3′-Hydroxycotinine Glucuronidation Does Not Alter the Nicotine Metabolite Ratio or Nicotine Intake. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/69j3x6rq
Background: CYP2A6 metabolizes nicotine to its primary metabolite cotinine and also mediates the metabolism of cotinine to trans-3′-hydroxycotinine (3HC). The ratio of 3HC to cotinine (the "nicotine metabolite ratio", NMR) is an in vivo marker for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::056b4de34810f6be7de8b218439dd81e
http://www.escholarship.org/uc/item/69j3x6rq
http://www.escholarship.org/uc/item/69j3x6rq
Autor:
Zhu, AZX, Cox, LS, Nollen, N, Faseru, B, Okuyemi, KS, Ahluwalia, JS, Benowitz, NL, Tyndale, RF
Publikováno v:
Zhu, AZX; Cox, LS; Nollen, N; Faseru, B; Okuyemi, KS; Ahluwalia, JS; et al.(2012). CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.. Clin Pharmacol Ther, 92(6), 771-777. doi: 10.1038/clpt.2012.186. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4nb2r46b
Bupropion is indicated to promote smoking cessation. Animal studies suggest that the pharmacologic activity of bupropion can be mediated by its major metabolite, hydroxybupropion. We measured plasma bupropion and its metabolite levels in a double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::9ceb143d8c26750176e7547cc462364f
http://www.escholarship.org/uc/item/4nb2r46b
http://www.escholarship.org/uc/item/4nb2r46b
Autor:
Bousquet, PJ, Cox, LS, Durham, SR, Nelson, HS, Passalacqua, G, Ryan, DP, Brozek, JL, Compalati, E, Dahl, R, Delgado, L, Gerth van Wijk, Roy, Gower, RG, Ledford, DK, Filho, NR, Valovirta, E, Yusuf, OM, Zuberbier, T
Publikováno v:
World Allergy Organization Journal, 233-281. BioMed Central Ltd.
STARTPAGE=233;ENDPAGE=281;ISSN=1939-4551;TITLE=World Allergy Organization Journal
STARTPAGE=233;ENDPAGE=281;ISSN=1939-4551;TITLE=World Allergy Organization Journal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::241e8053f849f64a9a0392f79b2aa60d
https://pure.eur.nl/en/publications/d9d5e995-1f53-468f-a9dc-75346de8eba2
https://pure.eur.nl/en/publications/d9d5e995-1f53-468f-a9dc-75346de8eba2